Protect (SDD)
Abstract
The Protect System Development & Demonstration (SDD) Project enhances mission performance and provides effective protection against current and emerging threats by rapidly developing and fielding modernized protection capabilities. Developmental efforts focus on advances in materials and systems engineering to enhance protective properties against a broader array of hazards, while reducing Countering Weapons of Mass Destruction (CWMD) operational challenges and logistical burdens. Developmental efforts focus on advanced medical countermeasures that provide safe and effective medical defenses against biological agents (bacteria, toxins, and viruses), emerging infectious diseases, and chemical agents. In FY 2023, the Chemical Biological Defense Program (CBDP) RDT&E Projects were restructured to align with the CBDP portfolio construct. PT5 efforts in FY 2022 remain in Projects IP5 and MB5. This restructuring provided standardization and alignment across CBDP research, development and acquisition efforts. Efforts included in this Project are: (1) Advanced System for Protection and Integrated Reduction of Encumbrances (ASPIRE) (2) ASPIRE-Enhanced Biodefense (ASPIRE-ENBD) (3) Botulinum Monoclonal Antibodies (BOT MAB) (4) Collective Protection Conex-Enhanced Biodefense (COL PRO CONEX-ENBD) (5) Portable Biocontainment Patient Transport System-Enhanced Biodefense (PPTS-ENBD) (6) Shipboard Isolation System (SIS) (7) Uniform Integrated Protection Ensemble Family of Systems Air (UIPE FOS AIR) (8) UIPE FOS General Purpose (UIPE FOS GP) (9) UIPE FOS Gloves (UIPE FOS GLOVES) (10) Special Immunizations Program (VAC SIP) (11) Rapid Access to Products in Development (RAPID) The Advanced System for Protection and Integrated Reduction of Encumbrances (ASPIRE) program allows near normal operations in a CBRN environment by minimizing or eliminating physical and psychological burden and increasing Warfighter lethality. The ASPIRE program will provide respiratory and ocular protection against CBRN threats. Multiple weapons system sights and enabling equipment are taking away space on the warfighter required to make existing protective masks work. Without this program we will be five to ten years late to need as this trend continues. The program will provide the capability to incorporate upgrades into the current ground masks to improve the suit hood/mask interface with Uniform Integrated Protective Ensemble Family of Systems General Purpose (UIPE FoS GP). In addition, this program, in conjunction with work by Joint Science and Technology Office (JSTO), will lay out the strategy and path forward required to minimize the burden to the warfighter while still providing respiratory and ocular protection against chemical, biological, radiological and nuclear agents. In FY24 the program will initiate optimization of the current ground mask systems to address suit hood/mask interface and conduct prototype build and evaluation of suit hood/mask interface improvements into current ground masks for down selection and refinement. Advanced System for Protection and Integrated Reduction of Encumbrances - Enhanced Biodefense (ASPIRE-ENBD), a new start program in FY24, supports unencumbering warfighters and revolutionizing respiratory and ocular protection against Chemical, Biological, Radiological and Nuclear (CBRN) threats, including protection from biological, toxic industrial chemicals, and other emerging threats. ASPIRE-ENBD provides a revolutionary new capability to address interface issues with new and emerging equipment. ASPIRE-ENBD will unencumber the warfighter while still providing respiratory and ocular protection against biological agents, provide durable and extended wear capability, and incorporate anti-microbial materials to develop a reusable respirator. The solution will be optimized to minimize impact on the wearer's performance to continue lethality in Biological environment by reducing burden, improving filtration capability, utilizing powered and supplied air systems as required, and integrate with existing and future equipment that cannot be integrated with current mask systems. ASPIRE-ENBD will provide a revolutionized capability to the Services for the next generation of respiratory and ocular protection. The ASPIRE-ENBD effort will develop half masks/bio-masks that are low-burden, provide protection against bio threats, and are designed as a reusable system with modularity and/or scalability for additional ocular protection. In FY24, the ASPIRE-ENBD program will initiate bio mask prototype development and evaluation. The Botulinum Monoclonal Antibodies (BOT MAB) program will develop and deliver Food and Drug Administration (FDA) approved Botulinum Monoclonal Antibodies to the warfighter. The BOT MAB will be a monoclonal antibody cocktail that protects warfighter against exposure to botulinum toxins A and B, which is the most lethal toxin known to man. Defense against this toxin is a known gap in defense to the warfighter. This product will do large scale Good Manufacturing Practices (GMP) in the DoD Advanced Development Manufacturing (ADM) facility. This is a transition from Science and Technology (S&T). Collective Protection CONEX Enhanced Biodefense (COL PRO CONEX-ENBD), a new start program in FY24, will provide a negative pressure shelter system for medical treatment of biologically contaminated patients in an Army field hospital environment. The Bio-Containment Shelter provides an isolation area to treat infectious personnel while preventing spread of the infection to other personnel. It is a modification of a standard two-side expandable International Standards Organization (ISO) shelter that integrates negative pressure containment systems that can be deployed with existing Army field hospitals to provide an isolation capability to Army field hospitals. In FY25, COL PRO CONEX will complete concept design, system planning and conduct an initial concept demonstration. Portable Patient Transport System-Enhanced Biodefense (PPTS-ENBD), a new start program in FY24, is a patient transport system that enables safe transport of asymptomatic, symptomatic, or infected patients while ensuring that the medical attending personnel and platform crew members are protected from exposure. In FY25, PPTS ENBD will Begin system test and evaluation and develop logistics products. Shipboard Isolation System (SIS) program is a new start in FY24, and will develop a kitted system that provides U.S. Navy ships the capability to setup an area to effectively isolate patients infected (or suspected of infection) with biological organisms or infectious disease. The SIS also allows medical staff to safely monitor and treat patients, and when necessary, provides a capability to safely evacuate patients off the ship. As a result, the spread of infectious disease among the crew will be minimized and the impact to mission readiness will be reduced significantly. Centers for Disease Control and Prevention (CDC) and DoD requirements for isolation and quarantine will be incorporated into the design of the SIS. In FY24, SIS will begin system planning and prototype development. The Uniform Integrated Protection Ensemble (UIPE) Family of Systems (FoS) Air program will provide the Warfighter percutaneous protection from operationally relevant traditional and non-traditional Chemical, Biological, Radiological, Nuclear (CBRN) threats. UIPE FoS Air will improve aircrew performance and survivability under CBRN conditions by reducing thermal burden and bulk, while increasing mobility and resulting in an increase operational effectiveness. The UIPE FoS Air is composed of two variants. The UIPE FoS Air Chemical, Biological, Radiological Layer (CBRL) to address the specific requirements of the United States Air Force (USAF) tactical/ejection fixed wing platforms and the Two Piece Undergarment (2PUG) to address the remaining USAF and United States Navy / United States Marine Corps tactical/ejection seat (rotary wing) and non-ejection (fixed wing) platforms. In FY23, UIPE FoS Air will finalize Engineering, Manufacturing and Developmental (EMD) testing and conduct integration testing on 40+ USAF, USN, and USMC platforms for airworthiness, safe to fly and final flight clearance. FY23 is last year of BA5 funding, program is transitioning to production. The Uniform Integrated Protective Ensemble Family of Systems General Purpose (UIPE FoS GP) is part of a family of systems that will give the Warfighter percutaneous protection from operationally relevant traditional, non-traditional, and advanced Chemical, Biological, Radiological and Nuclear (CBRN)/Toxic Industrial Material (TIM) threats likely to be encountered during joint force operations. The legacy chemical biological garment is nearing the end of its service life and does not meet updated requirements such as emerging threats, aerosol protection, and flame resistance. The UIPE FoS GP is a two-piece lightweight (compared to the legacy system) duty uniform replacement that has an aerosol liner, is flame resistant, and does not reduce Warfighter effectiveness in the areas of mobility and thermal burden. In FY24, program will conduct a Multi Service Operational Test and Evaluation (MOT&E) and continue low rate production. FY24 is last year of BA5 funding, program is transitioning to Production. Uniform Integrated Protective Ensemble (UIPE) Family of Systems (FoS) Gloves provides percutaneous protection to the hand and wrist interface of the warfighter against traditional and non-traditional Chemical, Biological, Radiological and Nuclear (CBRN) threats. UIPE FoS Gloves will provide improved comfort, tactility and dexterity and for certain mission profiles enhanced touch screen and flame resistant capability. The UIPE FoS Gloves will be developed using a Middle Tier Acquisition (MTA) approach. In FY24, the UIPE FoS Gloves program will conduct developmental testing and complete prototype development on multiple mission profiles (General Purpose, Aviation Heavy and Aviation Light). Conduct operational testing on prototypes for the multiple mission profiles. The Special Immunizations Program (VAC SIP) restructures to the Rapid Access to Products in Development (RAPID) program in FY24. VAC SIP continually manages, updates, and executes the Investigational New Drugs (INDs) of selected prophylaxis, treatments and diagnostics development products which provide additional protection to individuals that are at high risk of exposure to CBRN agents. DoD has the mission to maintain IND vaccines in Good Manufacturing Practice (GMP) storage and to conduct the periodic potency and stability testing of these materials to support submissions to the U.S. Food & Drug Administration (FDA). RAPID (Rapid Access to Products in Development) an FY24 restructure of the VAC SIP program, will allow access to prototype medical countermeasures that are being developed to differential states of readiness by storing and maintaining data packages and doses of countermeasures to enable Interim Fielding Capability (IFC), retargeting, or continued development as a Program of Record. RAPID will employ a tiered system to increase clarity of each Medical Countermeasures (MCMs) state of development and how quickly/costly it will be to achieve IFC.
Document Details
- Document Type
- Project
- Publication Date
- Oct 01, 2024
- Source ID
- PT5_0604384BP_5_0400_PB_2024
Related Documents
- Root: Chemical and Biological Defense Program - EMD
- Child Accomplishment: 1) ASPIRE
- Child Accomplishment: 2) ASPIRE-ENBD
- Child Accomplishment: 3) BOT MAB
- Child Accomplishment: 4) BOT MAB
- Child Accomplishment: 5) COL PRO CONEX-ENBD
- Child Accomplishment: 6) PPTS-ENBD
- Child Accomplishment: 7) SIS
- Child Accomplishment: 8) UIPE FOS AIR
- Child Accomplishment: 9) UIPE FOS GP
- Child Accomplishment: 10) UIPE FOS GLOVES
- Child Accomplishment: 11) VAC SIP
- Child Accomplishment: 12) RAPID
- Child Cost Item: c50b40719d80e000460ca335185f11d8
- Child Cost Item: b76a44d49c1cb9e720aa19c197957dc6
- Child Cost Item: d9a0c2d378ebfac7ca2d9cf304ccb703
- Child Cost Item: 003f068c87a53058dfdc1a2ef6303c63
- Child Cost Item: 766f2c0152350556beec834c86d091b3
- Child Cost Item: 6e2aef7259e902f3efc3e9ba29af632d
- Child Cost Item: d3f91cdd651f5123f133c3c13e6cfcd2
- Child Cost Item: 465bc8e0b142801b8eb63781c01b54d3
- Child Cost Item: 6daefcde13d3530532434fb73e0cc987
- Child Cost Item: 2f2b1c15f2a74f1a7b21d1c093fa4535
- Child Cost Item: 589408033d41aa2f3543f9b7fd1c7dc1
- Child Cost Item: b39ff66df87288fe4e5a930c2a3c433a
- Child Cost Item: 808c29d2644acf846a344f77a77818a5
- Child Cost Item: 1f2a40c1b032e37228b999f895c5173a
- Child Cost Item: db9034002983554998f7d02d93ad03bd
- Child Cost Item: eef5b357f68d7eb5ad581712932631e4
- Child Cost Item: f75d64ec98729bf9987c6060c6fbbd8e
- Child Cost Item: 874e3e7bd4c21c2e906a1e140af29265
- Child Cost Item: 1181f5a4d8e7c58134fc8332234c5647
- Child Cost Item: 6cf4a823291cf70184a37d06669dfc9a
- Child Cost Item: 270cad9f206610e6066c21557bee06b0
- Child Cost Item: 2110acf20b4bc3c7e21201b6374d2ed2
- Child Cost Item: 9c75c4124b4c124e67e3b92efca5a122
- Child Cost Item: b791f5f03848784d4af8a401da2671fa
- Child Cost Item: 4a3d7df44f5711f5f05c77e0eab6554b
- Child Cost Item: 6aa53c6690c00b58701eaaf19a51c46f
- Child Cost Item: b9f29c0e8e2d639750962c5326e38842
- Child Cost Item: a1a3c0847baf23b85c0cca002294efed
- Child Cost Item: 510a2a43c26059b7fd2f454c49775b07
- Child Cost Item: 84d669ebda609f3768ea9c39aa0e46c3
- Child Cost Item: 00fb921230e5bfb6b7cdba2d6ed68efd
- Child Cost Item: 4b73db53468e965995a6a377cef5eb24
- Child Cost Item: 3234080585a7c5445cc4b49ed3282060
- Child Cost Item: 7b7acb8eb397b970e8f5f3cd0d463f30
- Child Cost Item: 2c17c698169b1650364aa0db86b84a87
- Child Cost Item: 21377f5f505a0e982a6dee01949e1bd9
- Child Cost Item: 05095ee341efe130e8387107e5350800
- Child Cost Item: 49350244aeb745511097fbb6864c6a00
- Child Cost Item: ca1dc4d25ab6941f0739b8cda3a825f3
- Child Cost Item: 7431f3edaa84e6f0c747cf116fb5a899
- Child Cost Item: 312decaac7ecea1aa4bf69ed029a409d
- Child Cost Item: 749217904de0cf9d2bc09a0d56366433
- Child Cost Item: 78a2459b037604292e9e3128049ebe2a